J. Biol. Chem., Vol. 261, Issue 25, 11503-11511, Sep, 1986
Chemical conversion of aspartyl peptides to isoaspartyl peptides. A method for generating new methyl-accepting substrates for the erythrocyte D-aspartyl/L-isoaspartyl protein methyltransferase
PN McFadden and S Clarke
Mammalian protein carboxyl methyltransferases have recently been proposed
to recognize atypical configurations of aspartic acid and may possibly
function in the metabolism of covalently altered cellular proteins.
Consistent with this proposal, the tetrapeptide tetragastrin, containing a
single "normal" L-aspartyl residue (L-Trp-L-Met-L-Asp-L- Phe-NH2) was found
here not to be an in vitro substrate for erythrocyte carboxyl
methyltransferase activity. However, chemical treatment of tetragastrin by
methyl esterification and then de-esterification of the aspartic acid
residue yielded a mixture of peptide products, the major one of which could
now be enzymatically methylated. We show here that this new peptide species
is the isomeric beta-aspartyl form of tetragastrin (L-iso-tetragastrin;
L-Trp-L-Met-L-Asp-L-Phe-NH2), and it appears that isomerization proceeds
via an intramolecular succinimide intermediate during the de-esterification
procedure. L-iso-Tetragastrin is stoichiometrically methylated (up to 90%
in these experiments) with a Km for the enzyme of 5.0 microM. Similar
chemical treatment of several other L-aspartyl peptides also resulted in
the formation of new methyltransferase substrates. This general method for
converting normal aspartyl peptides to isoaspartyl peptides may have
application in the reverse process as well.